Andrew I.R. Maas1, Mark Dearden, Franco Servadei
1Department of Neurosurgery, Academic Hospital Rotterdam, The Netherlands; N.M. Dearden, Anaesthetic Department, Leeds General Infirmary, Leeds, United Kingdom; Department of Neurosurgery, Ospedale M. Bufalini, Cesena, Italy; Terapia Intensiva Neuroscienze, Ospedale Maggiore Policlinico IRCCS, Milano, Italy; ||Klinik für Neurochirurgie, Charité, Virchow-Klinikum, Medizinische Fakultät der Humboldt-Universität zu Berlin, Germany.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Early detection and prevention of secondary insults are key in managing head injuries. While neuroprotective agents show promise, evidence for their widespread benefit is limited, highlighting the need for improved guidelines and monitoring.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: